The α4β1 integrin in sickle cell disease

Transfusion Clinique et Biologique

Volumn 15, Issue 1-2, 2008, Pages 19-22

  Brittain, J E ^a   Parise, L V ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

4 1 integrin activation; Adhesion molecules; Sickle cell disease; Vaso occlusion

Indexed keywords

VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ADHESION; ERYTHROCYTE ADHESIVENESS; EXTRACELLULAR MATRIX; HUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RETICULOCYTE; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; DRUG ANTAGONISM; PHYSIOLOGY; REVIEW;

ANEMIA, SICKLE CELL; HUMANS; INTEGRIN ALPHA4BETA1; RETICULOCYTES;

EID: 49949152674     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2008.03.013     Document Type: Article

References (30)

1. Ager A., and Humphries M.J. Integrin alpha 4 beta 1: its structure, ligand-binding specificity and role in lymphocyte-endothelial cell interactions. Chem Immunol 50 (1991) 55-74
2. Humphries M.J., Sheridan J., Mould A.P., and Newham P. Mechanisms of VCAM-1 and fibronectin binding to integrin alpha 4 beta 1: implications for integrin function and rational drug design. Ciba Found Symp 189 (1995) 177-191
3. Liu S., Rose D.M., Han J., and Ginsberg M.H. Alpha4 integrins in cardiovascular development and diseases. Trends Cardiovasc Med 10 (2000) 253-257
4. Balcer L.J., Galetta S.L., Calabresi P.A., Confavreux C., Giovannoni G., Havrdova E., et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 68 (2007) 1299-1304
5. Kappos L., Bates D., Hartung H.P., Havrdova E., Miller D., Polman C.H., et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 6 (2007) 431-441
6. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348 (2003) 15-23
7. O'Connor P. Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosis. Expert Opin Biol Ther 7 (2007) 123-136
8. MacDonald JK, McDonald JW. Natalizumab for induction of remission in Crohn's disease. Cochrane. Database Syst Rev 2007, CD006097.
9. Ursell M.R., and O'Connor P.W. Natalizumab and other monoclonal antibodies. Neurol Clin 23 (2005) 233-246 viii
10. Holzmann B., Gosslar U., and Bittner M. alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immunol 231 (1998) 125-141
11. Coulombel L., Auffray I., Gaugler M.H., and Rosemblatt M. Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol 97 (1997) 13-21
12. Oostendorp R.A., Reisbach G., Spitzer E., Thalmeier K., Dienemann H., Mergenthaler H., et al. VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells. Br J Haematol 91 (1995) 275-284
13. Hyduk S.J., Oh J., Xiao H., Chen M., and Cybulsky M.I. Paxillin selectively associates with constitutive and chemoattractant-induced high-affinity alpha4beta1 integrins: implications for integrin signaling. Blood 104 (2004) 2818-2824
14. Eshghi S., Vogelezang M.G., Hynes R.O., Griffith L.G., and Lodish H.F. Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J Cell Biol 177 (2007) 871-880
15. Joneckis C.C., Ackley R.L., Orringer E.P., Wayner E.A., and Parise L.V. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82 (1993) 3548-3555
16. Swerlick R.A., Eckman J.R., Kumar A., Jeitler M., and Wick T.M. Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82 (1993) 1891-1899
17. Parise L.V., and Telen M.J. Erythrocyte adhesion in sickle cell disease. Curr Hematol Rep 2 (2003) 102-108
18. Kumar A., Eckmam J.R., Swerlick R.A., and Wick T.M. Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving alpha 4 beta 1 integrin receptors on sickle reticulocytes and fibronectin. Blood 88 (1996) 4348-4358
19. Brittain J.E., Mlinar K.J., Anderson C.S., Orringer E.P., and Parise L.V. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest 107 (2001) 1555-1562
20. Brittain J.E., Han J., Ataga K.I., Orringer E.P., and Parise L.V. Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem 279 (2004) 42393-42402
21. Brittain JE, Knoll CM, Ataga KI, Orringer EP, Parise LV. Fibronectin bridges monocytes and reticulocytes via integrin α4β1. Br J Haematol 2008, doi:10.1111/j.1365-2141.2008.07056.
22. Kaul D.K., Tsai H.M., Liu X.D., Nakada M.T., Nagel R.L., and Coller B.S. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood 95 (2000) 368-374
23. Charache S., Barton F.B., Moore R.D., Terrin M.L., Steinberg M.H., Dover G.J., et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 75 (1996) 300-326
24. Bartolazzi A., Jackson D., Bennett K., Aruffo A., Dickinson R., Shields J., et al. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108 Pt 4 (1995) 1723-1733
25. Verfaillie C.M., Benis A., Iida J., McGlave P.B., and McCarthy J.B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84 (1994) 1802-1811
26. Shattil S.J. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost 82 (1999) 318-325
27. El Nemer W., Wautier M.P., Rahuel C., Gane P., Hermand P., Galacteros F., et al. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell α4β1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood 109 (2007) 3544-3551
28. Hines P.C., Zen Q., Burney S.N., Shea D.A., Ataga K.I., Orringer E.P., et al. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood 101 (2003) 3281-3287
29. Zennadi R., Moeller B.J., Whalen E.J., Batchvarova M., Xu K., Shan S., et al. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood 110 (2007) 2708-2717
30. van den Berg J.M., Mul F.P., Schippers E., Weening J.J., Roos D., and Kuijpers T.W. Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin. Eur J Immunol 31 (2001) 276-284